For the first time in over a decade, obesity rates in the United States may finally be heading in the right direction and new weight loss drugs like semaglutide could be part of the reason why.

Eli Lilly (LLY 0.86%) and Novo Nordisk (NVO -1.53%) have competed for decades. They're both leaders in the areas of insulin ...

With drugs like Novo Nordisk's Wegovy becoming household names over the last couple of years, it's no surprise that there are ...

Investing.com -- The global obesity epidemic represents one of the most pressing ... Beyond lifestyle, biological mechanisms ...

Dr. Darien Sutton joins GMA to discuss whether weight loss drugs are having an impact on dropping obesity rates.